Olivier Deckmyn

918 total citations
23 papers, 603 citations indexed

About

Olivier Deckmyn is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Olivier Deckmyn has authored 23 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Olivier Deckmyn's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (7 papers). Olivier Deckmyn is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (7 papers). Olivier Deckmyn collaborates with scholars based in France, United States and Switzerland. Olivier Deckmyn's co-authors include Vlad Ratziu, M. Munteanu, Yen Ngo, Thierry Poynard, Dominique Thabut, Thierry Poynard, Chantal Housset, Marika Rudler, Pascal Lebray and Vincent Thibault and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Olivier Deckmyn

23 papers receiving 590 citations

Peers

Olivier Deckmyn
Jinho Jung United States
Olivier Deckmyn
Citations per year, relative to Olivier Deckmyn Olivier Deckmyn (= 1×) peers Jinho Jung

Countries citing papers authored by Olivier Deckmyn

Since Specialization
Citations

This map shows the geographic impact of Olivier Deckmyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Deckmyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Deckmyn more than expected).

Fields of papers citing papers by Olivier Deckmyn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Deckmyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Deckmyn. The network helps show where Olivier Deckmyn may publish in the future.

Co-authorship network of co-authors of Olivier Deckmyn

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Deckmyn. A scholar is included among the top collaborators of Olivier Deckmyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Deckmyn. Olivier Deckmyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Poynard, Thierry, Olivier Deckmyn, Valentina Peta, et al.. (2023). Prospective direct comparison of non‐invasive liver tests in outpatients with type 2 diabetes using intention‐to‐diagnose analysis. Alimentary Pharmacology & Therapeutics. 58(9). 888–902. 5 indexed citations
2.
Poynard, Thierry, Olivier Deckmyn, Valentina Peta, et al.. (2023). Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia. Hepatology Communications. 7(10). 3 indexed citations
3.
Maisonnasse, Pauline, Thierry Poynard, Mehdi Sakka, et al.. (2022). Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection. SHILAP Revista de lepidopterología. 1(3). 393–402. 3 indexed citations
4.
Poynard, Thierry, Olivier Deckmyn, Valentina Peta, et al.. (2022). External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B. SHILAP Revista de lepidopterología. 1(4). 604–617. 1 indexed citations
5.
Poynard, Thierry, Olivier Deckmyn, Valentina Peta, et al.. (2021). External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV. JHEP Reports. 3(4). 100298–100298. 4 indexed citations
6.
Poynard, Thierry, Valentina Peta, Olivier Deckmyn, et al.. (2019). Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. European Journal of Gastroenterology & Hepatology. 32(8). 998–1007. 9 indexed citations
7.
Munteanu, M., Raluca Pais, Valentina Peta, et al.. (2018). Long‐term prognostic value of the FibroTest in patients with non‐alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease. Alimentary Pharmacology & Therapeutics. 48(10). 1117–1127. 30 indexed citations
8.
Poynard, Thierry, Valentina Peta, M. Munteanu, et al.. (2018). The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis. European Journal of Gastroenterology & Hepatology. 31(3). 393–402. 15 indexed citations
9.
Poynard, Thierry, M. Munteanu, Frédéric Charlotte, et al.. (2018). Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference. European Journal of Gastroenterology & Hepatology. 30(5). 569–577. 15 indexed citations
10.
11.
Poynard, Thierry, M. Munteanu, Frédéric Charlotte, et al.. (2017). Impact of steatosis and inflammation definitions on the performance of NASH tests. European Journal of Gastroenterology & Hepatology. 30(4). 384–391. 12 indexed citations
12.
Munteanu, M., Dina Tiniakos, Quentin M. Anstee, et al.. (2016). Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Alimentary Pharmacology & Therapeutics. 44(8). 877–889. 69 indexed citations
13.
Poynard, Thierry, Tam N. Pham, Hugo Perazzo, et al.. (2016). Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison. PLoS ONE. 11(10). e0163276–e0163276. 27 indexed citations
14.
Poynard, Thierry, Olivier Deckmyn, M. Munteanu, et al.. (2015). Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity. BMJ Open. 5(12). e010017–e010017. 8 indexed citations
15.
Poynard, Thierry, Julien Vergniol, Yen Ngo, et al.. (2014). Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®). Journal of Hepatology. 61(5). 994–1003. 37 indexed citations
16.
Poynard, Thierry, J. Moussalli, M. Munteanu, et al.. (2013). Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C. Journal of Hepatology. 59(4). 675–683. 120 indexed citations
17.
Poynard, Thierry, M. Munteanu, Olivier Deckmyn, et al.. (2012). Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population. Journal of Hepatology. 57(3). 541–548. 65 indexed citations
18.
Poynard, Thierry, M. Munteanu, Olivier Deckmyn, et al.. (2011). Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age. BMC Gastroenterology. 11(1). 39–39. 52 indexed citations
19.
Poynard, Thierry, Dominique Thabut, P. Jabre, et al.. (2011). Ranking Hepatologists: Which Hirsch's h-Index to prevent the “e-crise de foi-e”?. Clinics and Research in Hepatology and Gastroenterology. 35(5). 375–386. 24 indexed citations
20.
Poynard, Thierry, Dominique Thabut, M. Munteanu, et al.. (2010). Hirsch Index and Truth Survival in Clinical Research. PLoS ONE. 5(8). e12044–e12044. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026